贝氏柯克斯体感染

Hartzell JD, Wood-Morris RN, Martinez LJ, et al. Q fever: Epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2008;83:574-579.

• 全文
• 摘要

Eldin C, Mélenotte C, Mediannikov O, et al. From Q fever to Coxiella burnetii infection: a paradigm change. Clin Microbiol Rev. 2017;30:115-190.

• 摘要

Maurin M, Raoult D. Q fever. Clin Microbiol Rev. 1999;12:518-553.

• 全文
• 摘要

Parker NR, Barralet JH, Bell AM. Q fever. Lancet. 2006;367:679-688.

• 摘要

Raoult D, Marrie T, Mege J. Natural history and pathophysiology of Q fever. Lancet Inf Dis. 2005;5:219-226.

• 摘要

1.  Marrie TJ, Raoult D. Coxiella burnetii. In Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 6th ed. Philadelphia, PA: Churchill Livingstone; 2005.

2.  Hartzell JD, Wood-Morris RN, Martinez LJ, et al. Q fever: Epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2008;83:574-579.

• 全文
• 摘要

3.  Eldin C, Mélenotte C, Mediannikov O, et al. From Q fever to Coxiella burnetii infection: a paradigm change. Clin Microbiol Rev. 2017;30:115-190.

• 摘要

4.  Million M, Roblot F, Carles D, et al. Reevaluation of the risk of fetal death and malformation after Q fever. Clin Infect Dis. 2014;59:256-260.

• 全文
• 摘要

5.  Maurin M, Raoult D. Q fever. Clin Microbiol Rev. 1999;12:518-553.

• 全文
• 摘要

6.  Parker NR, Barralet JH, Bell AM. Q fever. Lancet. 2006;367:679-688.

• 摘要

7.  Ordi-Ros J, Selva-O'Callaghan A, Monegal-Ferran F, et al. Prevalence, significance, and specificity of antibodies to phospholipids in Q fever. Clin Infect Dis. 1994;18:213-218.

• 摘要

8.  Newcombe JP, Gray PE, Palasanthiran P, et al. Q Fever with transient antiphospholipid antibodies associated with cholecystitis and splenic infarction. Pediatr Infect Dis J. 2013;32:415-416.

• 摘要

9.  Million M, Thuny F, Bardin N, et al. Antiphospholipid antibody syndrome with valvular vegetations in acute Q fever. Clin Infect Dis. 2016;62:537-544.

• 摘要

10.  Lee CH, Chuah SK, Pei SN, et al. Acute Q fever presenting as antiphospholipid syndrome, pneumonia, and acalculous cholecystitis and masquerading as Mycoplasma pneumoniae and hepatitis C viral infections. Jpn J Infect Dis. 2011;64:525-527.

• 全文
• 摘要

11.  Melenotte C, Million M, Audoly G, et al. B-cell non-Hodgkin lymphoma linked to Coxiella burnetii. Blood. 2016;127:113-121.

• 摘要

12.  Million M, Walter G, Thuny F, et al. Evolution from acute Q fever to endocarditis is associated with underlying valvulopathy and age and can be prevented by prolonged antibiotic treatment. Clin Infect Dis. 2013;57:836-844.

• 全文
• 摘要

13.  Ergas D, Abdul-Hai A, Sthoeger ZM. Acalculous cholecystitis: an unusual presentation of acute Q fever masquerading as infectious endocarditis. Am J Med Sci. 2008;336:356-357.

• 摘要

14.  Grisoli D, Million M, Edouard S, et al. Latent Q fever endocarditis in patients undergoing routine valve surgery. J Heart Valve Dis. 2014;23:735-743.

• 摘要

15.  Edouard S, Million M, Lepidi H, et al. Persistence of DNA in a cured patient and positive culture in cases with low antibody levels bring into question diagnosis of Q fever endocarditis. J Clin Microbiol. 2013;51:3012-3017.

• 全文
• 摘要

16.  Million M, Halfon J, Le Lez ML, et al. Relapsing uveitis and optic neuritis due to chronic Q fever. Br J Ophthalmol. 2011;95:1026-1027.

• 摘要

17.  Odeh M, Oliven A. Temporal arteritis associated with acute Q fever. A case report. Angiology. 1994;45:1053-1057.

• 摘要

18.  Lefebvre M, Grossi O, Agard C, et al. Systemic immune presentations of Coxiella burnetii infection (Q fever). Semin Arthritis Rheum. 2010;39:405-409.

• 摘要

19.  Baziaka F, Karaiskos I, Galani L, et al. Large vessel vasculitis in a patient with acute Q-fever: a case report. IDCases. 2014;1:56-59.

• 全文
• 摘要

20.  Raoult D, Tissot-Dupont H, Foucault C, et al. Q fever 1985-1998: clinical and epidemiologic features of 1,383 infections. Medicine. 2000;79:109-123.

• 摘要

21.  Tissot-Dupont H, Raoult D, Brouqui P, et al. Epidemiologic features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases. Am J Med. 1992;93:427-434.

• 摘要

22.  Houpikian P, Habib G, Mesana T, et al. Changing clinical presentation of Q fever endocarditis. Clin Infect Dis. 2002;34:e28-e31.

• 全文
• 摘要

23.  Lepe JA, Guerrero FJ, Ruiz-Calderon A, et al. The epidemiology of Q fever in the northern area of Huelva, Spain. Enferm Infecc Microbiol Clin. 1999;17:65-68.

• 摘要

24.  Gidding HF, Wallace C, Lawrence GL, et al. Australia's national Q fever vaccination program. Vaccine. 2009;27:2037-2041.

• 摘要

25.  Karakousis PC, Trucksis M, Dumler JS. Chronic Q fever in the United States. J Clin Microbiol. 2006;44:2283-2287.

• 全文
• 摘要

26.  Limonard GJ, Peters JB, Nabuurs-Franssen MH, et al. Detailed analysis of health status of Q fever patients 1 year after the first Dutch outbreak: a case-control study. QJM. 2010;103:953-958.

• 全文
• 摘要

27.  Morroy G, Peters JB, van Nieuwenhof M, et al. The health status of Q-fever patients after long-term follow-up. BMC Infect Dis. 2011;11:97.

• 全文
• 摘要

28.  Van Steenbergen JE, Morroy G, Groot CA, et al. An outbreak of Q fever in The Netherlands - possible link to goats. Ned Tijdschr Geneeskd. 2007;151:1998-2003.

• 摘要

29.  Klaassen CH, Nabuurs-Franssen MH, Tilburg JJ, et al. Multigenotype Q fever outbreak, the Netherlands. Emerg Infect Dis. 2009;15:613-614.

• 全文
• 摘要

30.  Voelker R. Risk of exposure to Q fever pathogen boosted by travel in Iraq or Netherlands. JAMA. 2010;303:2345.

• 摘要

31.  Amitai Z, Bromberg M, Bernstein M, et al. A large Q fever outbreak in an urban school in central Israel. Clin Infect Dis. 2010;50:1433-1438.

• 摘要

32.  Ergas D, Keysari A, Edelstein V, et al. Acute Q fever in Israel: clinical and laboratory study of 100 hospitalized patients. Isr Med Assoc J. 2006;8:337-341.

• 全文
• 摘要

33.  Lai CH, Huang CK, Chin C. Acute Q fever: an emerging and endemic disease in southern Taiwan. Scand J Infect Dis. 2008;40:105-110.

• 摘要

34.  Gleeson TD, Decker CF, Johnson MD, et al. Q fever in US military returning from Iraq. Am J Med. 2007;120:e11-e12.

• 全文
• 摘要

35.  Anderson AD, Baker TR, Littrell AC, et al. Seroepidemiologic survey for Coxiella burnetii among hospitalized US troops deployed to Iraq. Zoonoses Public Health. 2011;58:276-283.

• 摘要

36.  Ta TH, Jiménez B, Navarro M, et al. Q fever in returned febrile travelers. J Travel Med. 2008;15:126-129.

• 全文
• 摘要

37.  Cohen NJ, Papernik M, Singleton J, et al. Q fever in an American tourist returned from Australia. Travel Med Infect Dis. 2007;5:194-195.

• 摘要

38.  Milazzo A, Hall R, Storm PA, et al. Sexually transmitted Q fever. Clin Infect Dis. 2001;33:399-402.

• 全文
• 摘要

39.  Pantanowitz L, Telford SR, Cannon ME. Tick-borne diseases in transfusion medicine. Transfus Med. 2002;12:85-106.

• 摘要

40.  Hall CJ, Richmond SJ, Caul EO, et al. Laboratory outbreak of Q fever acquired from sheep. Lancet. 1982;1:1004-1006.

• 摘要

41.  Meiklejohn G, Reimer LG, Graves PS, et al. Cryptic epidemic of Q fever in a medical school. J Infect Dis. 1981;144:107-113.

• 摘要

42.  Leone M, Honstettre A, Lepidi H, et al. Effect of sex on Coxiella burnetii infection: protective role of 17beta-estradiol. J Infect Dis. 2004;189:339-345.

• 全文
• 摘要

43.  Stein A, Saunders NA, Taylor AG, et al. Phylogenic homogeneity of Coxiella burnetii strains as determinated by 16S ribosomal RNA sequencing. FEMS Microbiol Lett. 1993;113:339-344.

• 摘要

44.  Salmon MM, Howells B, Glencross EJ, et al. Q fever in an urban area. Lancet. 1982;1:1002-1004.

• 摘要

45.  Baca OG. Pathogenesis of rickettsial infections emphasis on Q fever. Eur J Epidemiol. 1991;7:222-228.

• 摘要

46.  Honstettre A, Imbert G, Ghigo E, et al. Dysregulation of cytokines in acute Q fever: role of interleukin-10 and tumor necrosis factor in chronic evolution of Q fever. J Infect Dis. 2003;187:956-962.

• 摘要

47.  Raoult D, Levy PY, Dupont HT, et al. Q fever and HIV infection. AIDS. 1993;7:81-86.

• 摘要

48.  McCaul TF, Williams JC. Development cycle of Coxiella burnetii: structure and morphogenesis of vegetative and sporogenic differentiations. J Bacteriol. 1981;147:1063-1076.

• 全文
• 摘要

49.  Q fever. In: Christie AB, ed. Infectious diseases, epidemiology and clinical practice. Edinburgh, UK: Churchill Livingstone; 1974:876-891.

50.  Centers for Disease Control. Q fever outbreak - Switzerland. MMWR Morb Mortal Wkly Rep. 1984;33:355-356,361.

• 全文
• 摘要

51.  Baud D, Greub G. Intracellular bacteria and adverse pregnancy outcomes. Clin Microbiol Infect. 2011:17;1312-1322.

• 摘要

52.  Chiu CK, Durrheim DN. A review of the efficacy of human Q fever vaccine registered in Australia. N S W Public Health Bull. 2007;18:133-136.

• 全文
• 摘要

53.  Marmion B, Harris R, Strom P, et al. Q Fever Research Group (QRG), Adelaide, activities-exit summary 1980-2004. Ann N Y Acad Sci. 2005;1063:181-186.

• 摘要

54.  Ackland JR, Worswick DA, Marmion BP. Vaccine prophylaxis of Q fever: a follow up study of the efficacy of Q-vax (CSL) 1985-1990. Med J Aust. 1994;160:704-708.

• 摘要

55.  O'Neill TJ, Sargeant JM, Poljak Z. The effectiveness of Coxiella burnetii vaccines in occupationally exposed populations: a systematic review and meta-analysis. Zoonoses Public Health. 2014;61:81-96.

• 摘要

56.  Raoult D, Marrie T, Mege J. Natural history and pathophysiology of Q fever. Lancet Inf Dis. 2005;5:219-226.

• 摘要

57.  Wilson HG, Neilson GH, Galea EG, et al. Q fever endocarditis in Queensland. Circulation. 1976;53:680-684.

• 摘要

58.  Drancourt M, Raoult D, Xeridat B, et al. Q fever meningoencephalitis in five patients. Eur J Epidemiol. 1991;7:134-138.

• 摘要

59.  Bernit E, Pouget J, Janbon F, et al. Neurological involvement in acute Q fever: a report of 29 cases and review of the literature. Arch Intern Med. 2002;162:693-700.

• 全文
• 摘要

60.  Wildman MJ, Smith EG, Groves J, et al. Chronic fatigue following infection by Coxiella burnetii (Q fever): ten-year follow-up of the 1989 UK outbreak cohort. QJM. 2002;95:527-538.

• 全文
• 摘要

61.  Ayres JG, Wildman M, Groves J, et al. Long-term follow-up of patients from the 1989 Q fever outbreak: no evidence of excess cardiac disease in those with fatigue. QJM. 2002;95:539-546.

• 全文
• 摘要

62.  Aarthi P, Bagyalakshmi R, Mohan R, et al. First case series of emerging Rickettsial neonatal sepsis identified by polymerase chain reaction-based deoxyribonucleic acid sequencing. Indian J Med Microbiol. 2013;31:343-348.

• 全文
• 摘要

63.  Suárez Ortega S, Rivero Vera J, Hemmersbach M, et al. Severe cholestatic hepatitis due to Q fever: report of a case [in Spanish]. Gastroenterol Hepatol. 2010;33:21-24.

• 全文
• 摘要

64.  Million M, Walter G, Bardin N, et al. Immunoglobulin G anticardiolipin antibodies and progression to Q fever endocarditis. Clin Infect Dis. 2013;57:57-64.

• 全文
• 摘要

65.  Marrie TJ, Raoult D. Rickettsial infections of the central nervous system. Semin Neurol. 1992;12:213-224.

• 摘要

66.  Issartel B, Gauduchon V, Chalabreysse L. Clinically and histologically silent Q fever endocarditis accidentally diagnosed by PCR. Clin Microbiol Infect. 2002;8:113-114.

• 全文
• 摘要

67.  Frangoulidis D, Rodolakis A, Heiser V. DNA microarray-chip based diagnosis of Q-fever (Coxiella burnetii). Clin Microbiol Infect. 2009;15:165-166.

• 摘要

68.  Edouard S, Raoult D. Lyophilization to improve the sensitivity of qPCR for bacterial DNA detection in serum: the Q fever paradigm. J Med Microbiol. 2016;65:462-467.

• 摘要

69.  Million M, Raoult D. The pathogenesis of the antiphospholipid syndrome. N Engl J Med. 2013;368:2335.

• 摘要

70.  Eldin C, Melenotte C, Million M, et al. 18F-FDG PET/CT as a central tool in the shift from chronic Q fever to Coxiella burnetii persistent focalized infection: a consecutive case series. Medicine (Baltimore). 2016;95:e4287.

• 摘要

71.  Bailey MS, Trinick TR, Dunbar JA, et al. Undifferentiated febrile illnesses amongst British troops in Helmand, Afghanistan. J R Army Med Corps. 2011;157:150-155.

• 摘要

72.  Raoult D. Chronic Q fever: expert opinion versus literature analysis and consensus. J Infect. 2012;65:102-108.

• 摘要

73.  Million M, Bellevegue L, Labussiere AS, et al. Culture-negative prosthetic joint arthritis related to Coxiella burnetii. Am J Med. 2014;127:786.

• 摘要

74.  Million M, Thuny F, Richet H, et al. Long-term outcome of Q fever endocarditis: a 26-year personal survey. Lancet Infect Dis. 2010;10:527-535.

• 摘要

75.  Dijkstra F, Riphagen-Dalhuisen J, Wijers N, et al. Antibiotic therapy for acute Q fever in The Netherlands in 2007 and 2008 and its relation to hospitalization. Epidemiol Infect. 2011;139:1332-1341.

• 摘要

76.  Schmidt-Tanguy A, Voswinkel J, Henrion D, et al. Antithrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients. J Thromb Haemost. 2013;11:1927-1929.

• 摘要

77.  Espinola RG, Pierangeli SS, Gharavi AE, et al. Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies. Thromb Haemost. 2002;87:518-522.

• 摘要

78.  Edwards MH, Pierangeli S, Liu X, et al. Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice. Circulation. 1997;96:4380-4384.

• 全文
• 摘要

79.  Belizna C. Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome. Autoimmun Rev. 2015;14:358-362.

• 摘要

80.  Nuri E, Taraborelli M, Andreoli L, et al. Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome. Immunol Res. 2016 Jul 13 [Epub ahead of print].

• 摘要

81.  Broder A, Putterman C. Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and/or lupus anticoagulant in systemic lupus erythematosus. J Rheumatol. 2013;40:30-33.

• 全文
• 摘要

82.  Fenollar F, Fournier PE, Carrieri MP, et al. Risks factors and prevention of Q fever endocarditis. Clin Infect Dis. 2001;33:312-316.

• 全文
• 摘要

83.  Anderson A, Bijlmer H, Fournier PE, et al. Diagnosis and management of Q fever - United States, 2013: recommendations from CDC and the Q Fever Working Group. MMWR Recomm Rep. 2013;62:1-30.

• 全文
• 摘要

84.  Carcopino X, Raoult D, Bretelle F, et al. Managing Q fever during pregnancy: the benefits of long term cotrimoxazole therapy. Clin Infect Dis. 2007;45:548-555.

• 全文
• 摘要

85.  Cerar D, Karner P, Avsic-Zupanc T, et al. Azithromycin for acute Q fever in pregnancy. Wien Klin Wochenschr. 2009;121:469-472.

• 摘要

86.  Oteo JA, Pérez-Cortés S, Santibáñez P, et al. Q fever endocarditis associated with a cardiovascular implantable electronic device. Clin Microbiol Infect. 2012;18:E482-E484.

• 全文
• 摘要

87.  Eldin C, Mailhe M, Lions C, et al. Treatment and prophylactic strategy for Coxiella burnetii infection of aneurysms and vascular grafts: a retrospective cohort study. Medicine (Baltimore). 2016;95:e2810.

• 全文
• 摘要

88.  Rolain JM, Mallet MN, Raoult D. Correlation between serum doxycycline concentrations and serologic evolution in patients with Coxiella burnetii endocarditis. J Infect Dis. 2003;188:1322-1325.

• 全文
• 摘要

89.  Rolain JM, Boulos A, Mallet MN, et al. Correlation between ratio of serum doxycycline concentration to MIC and rapid decline of antibody levels during treatment of Q fever endocarditis. Antimicrob Agents Chemother. 2005;49:2673-2676.

• 全文
• 摘要

90.  Lecaillet A, Mallet MN, Raoult D, et al. Therapeutic impact of the correlation of doxycycline serum concentrations and the decline of phase I antibodies in Q fever endocarditis. J Antimicrob Chemother. 2009;63:771-774.

• 全文
• 摘要

91.  Skiba V, Barner KC. Central nervous system manifestations of Q fever responsive to steroids. Mil Med. 2009;174:857-859.

• 摘要

92.  Fernández-Ruiz M, López-Medrano F, Alonso-Navas F, et al. Coxiella burnetii infection of left atrial thrombus mimicking an atrial myxoma. Int J Infect Dis. 2010;14(suppl 3):e319-e321.

• 摘要

93.  Spyridaki I, Psaroulaki A, Vranakis I, et al. Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and its comparison with those of six other antibiotics. Antimicrob Agents Chemother. 2009;53:2690-2692.

• 摘要

94.  Langley JM, Marrie TJ, Leblanc JC, et al. Coxiella burnetii seropositivity in parturient women is associated with adverse pregnancy outcomes. Am J Obstet Gynecol. 2003;189:228-232.

• 摘要

95.  NASPHV; Centers for Disease Control and Prevention; Council of State and Territorial Epidemiologists; American Veterinary Medical Association. Compendium of measures to prevent disease associated with animals in public settings, 2009: National Association of State Public Health Veterinarians, Inc. (NASPHV). MMWR Recomm Rep. 2009;58:1-21.

• 全文
• 摘要

96.  Moodie CE, Thompson HA, Meltzer MI, et al. Prophylaxis after exposure to Coxiella burnetii. Emerg Infect Dis. 2008;14:1558-1566.

• 全文
• 摘要